With an aggregate of $11 million raised in an initial Series A funding round, Doron Therapeutics is advancing its lead ...

Declining blood levels of two molecules that occur naturally in the body track closely with worsening Alzheimer’s disease, particularly in women. Levels were found to drop gradually, from women with ...